Susquehanna International Group’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Susquehanna International Group’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-60,459	Closed	-$611K	–	14154
2022 Q4	$611K	Hold	60,459	–	–	﹤0.01%	7340
2022 Q3	$600K	Buy	+60,459	New	+$597K	﹤0.01%	7994
2022 Q2	–	Sell	-60,522	Closed	-$596K	–	14411
2022 Q1	$596K	Sell	60,522 -35	-0.1%	-$345	﹤0.01%	8512
2021 Q4	$596K	Sell	60,557 -82	-0.1%	-$805	﹤0.01%	8707
2021 Q3	$591K	Buy	60,639 +180	+0.3%	+$1.74K	﹤0.01%	8935
2021 Q2	$585K	Buy	+60,459	New	+$587K	﹤0.01%	9222

Susquehanna International Group's BIOT Position: Q1 2023 in Review

Susquehanna International Group sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 60,459 shares — an estimated $611K sold.

Susquehanna International Group first reported a position in BIOT in Q2 2021 and held it in 6 quarters. The position peaked at $611K in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Susquehanna International Group reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Susquehanna International Group sold 60,459 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $611K.
Susquehanna International Group first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2021 and held it in 6 quarters.
Susquehanna International Group's Biotech Acquisition Company Class A Ordinary Shares position peaked at $611K in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.